Various surveys claim that about three million cases of IPF are reported all over the globe, resulting in the need for effective pulmonary fibrosis treatment. The Pulmonary Fibrosis Foundation states that a major portion of pulmonary fibrosis cases occurs in individuals aging above 40 years. Developers of the pulmonary fibrosis treatment medication are chiefly in …
Continue reading “Market Players Seek Regulatory Approvals for Pulmonary Fibrosis Treatment Drugs”